CD8A and infection: CD45.1+ TCR-transgenic P14 CD8 T cells recognizing the LCMV-derived gp33–41 peptide were adoptively transferred into CD45.2+ hosts one day prior infection with a low (200 ffu) or high (2 × 106 ffu) dose of LCMV clone 13 to induce an acute or chronic infection.